Publications

Journal Article
Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Ppublish 337 citations
Electronic publication date
March 15, 1991

View on Pubmed.gov 2006182 | View on doi.org 10.1073/pnas.88...

Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.

Search for publications in this journal Proc Natl Acad Sci U S A - 88(6):2441-5

Abstract

Although commonly used to control a variety of inflammatory diseases, the mechanism of action of a low dose of methotrexate remains a mystery. Methotrexate accumulates intracellularly where it may interfere with purine metabolism. Therefore, we determined whether a 48-hr pretreatment with methotrexate affected adenosine release from [14C]adenine-labeled human fibroblasts and umbilical vein endothelial cells. Methotrexate significantly increased adenosine release by fibroblasts from 4 +/- 1% to 31 +/- 6% of total purine released (EC50, 1 nM) and by endothelial cells from 24 +/- 4% to 42 +/- 7%. Methotrexate-enhanced adenosine release from fibroblasts was further increased to 51 +/- 4% (EC50, 6 nM) and from endothelial cells was increased to 58 +/- 5% of total purine released by exposure to stimulated (fMet-Leu-Phe at 0.1 microM) neutrophils. The effect of methotrexate on adenosine release was not due to cytotoxicity since cells treated with maximal concentrations of methotrexate took up [14C]adenine and released 14C-labeled purine (a measure of cell injury) in a manner identical to control cells. Methotrexate treatment of fibroblasts dramatically inhibited adherence to fibroblasts by both unstimulated neutrophils (IC50, 9 nM) and stimulated neutrophils (IC50, 13 nM). Methotrexate treatment inhibited neutrophil adherence by enhancing adenosine release from fibroblasts since digestion of extracellular adenosine by added adenosine deaminase completely abrogated the effect of methotrexate on neutrophil adherence without, itself, affecting adherence. One hypothesis that explains the effect of methotrexate on adenosine release is that, by inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase, methotrexate induces the accumulation of AICAR, the nucleoside precursor of which (5-aminoimidazole-4-carboxamide ribonucleoside referred to hereafter as acadesine) has previously been shown to cause adenosine release from ischemic cardiac tissue. We found that acadesine also promotes adenosine release from and inhibits neutrophil adherence to connective tissue cells. The observation that the antiinflammatory actions of methotrexate are due to the capacity of methotrexate to induce adenosine release may form the basis for the development of an additional class of antiinflammatory drugs.

References

J Leukoc Biol. 1985 May;37(5):545-57

Scand J Clin Lab Invest Suppl. 1968;97:77-89

J Immunol. 1985 Aug;135(2):1366-71

Proc Natl Acad Sci U S A. 1985 Aug;82(15):4881-5

Cited by 337 citations (total)

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Molecular action of methotrexate in inflammatory diseases.

Electronic publication date December 13, 2002

Search for publications in this journal Arthritis Res

Edwin S L Chan [...] Bruce N Cronstein et al.

Despite the recent introduction of biological response modifiers and potent new small-molecule antirheumatic drugs, the efficacy of methotrexate is nearly...

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Role of NADPH oxidase in formation and function of multinucleated giant cells.

Electronic publication date May 12, 2010

Search for publications in this journal J Innate Immun

Mark T Quinn [...] Igor A Schepetkin et al.

Macrophages play essential roles in a wide variety of physiological and pathological processes. One of the unique features of these...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances